Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis.
Head Tracking Latency in Virtual Environments Revisited: Do Users with Multiple Sclerosis Notice Latency Less?
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Microwave & magnetic (M(2) ) proteomics of the EAE animal model of multiple sclerosis.
Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study.
On the role of natural killer cells in neurodegenerative diseases.
[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis.
Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
The role of IL-6 in the expression of PD-1 and PDL-1 on CNS cells following infection with Theiler's murine encephalomyelitis virus.
Impaired early B cell tolerance in patients with rheumatoid arthritis.
OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.
PS3-16: Access and Collaboration with the Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH).
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
Optic neuritis: Experience from a south Indian demyelinating disease registry.
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
Diagnosing neuromyelitis optica.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials.

Pages